Healthcare -
Biotechnology - NASDAQ - US
$ 15.5
-6.4 %
$ 2.25 B
Market Cap
-6.03
P/E
DNLI - OTHER LONG-TERM ASSETS
Other Long-term Assets DNLI - Denali Therapeutics Inc.
18.1 M
LAST VALUE
23.63%
2 YEAR CAGR
17.49%
5 YEAR CAGR
0.00%
10 YEAR CAGR